HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Webb, W. R. Articles by Breaux, J. Search for Related Content PubMed PubMed Citation Articles by Webb, W. R. Articles by Breaux, J.

The Journal of Thoracic and Cardiovascular Surgery, Vol 103, 881-885, Copyright © 1992 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Iodized talc pleurodesis for the treatment of pleural effusions

WR Webb, V Ozmen, PV Moulder, B Shabahang and J Breaux
Department of Surgery, Tulane University School of Medicine, New Orleans, LA 70112.

This prospective study was designed to determine the efficacy of iodized talc pleurodesis in patients with pleural effusions. Thirty- four patients underwent this treatment (three bilaterally) between October 1, 1989, and March 31, 1991. All patients had to have complete or nearly complete lung reexpansion after tube thoracostomy with fluid drainage less than 100 ml in 24 hours. A slurry containing 5 gm of talc and 3 gm of thymol iodide was instilled into the pleural space through the chest tube. Chest tubes were removed after complete reexpansion and clearing of the effusions, usually in 3 to 5 days. The patients' ages ranged from 26 to 88 years (average 50 years). Eighteen patients had lung carcinoma, two had mesothelioma, and one each had carcinoma of the ovary, breast, or anorectum, multiple myeloma, schwannoma, or Hodgkin's lymphoma. Two patients had an unknown adenocarcinoma primary and five other patients had acquired immunodeficiency syndrome. One patient had congestive heart failure. Nineteen patients had left, 12 had right, and three had bilateral pleural effusions. The effusion was serosanguineous in 26 and serofibrinous in eight patients. Serial chest radiography showed complete response in all patients. The period of follow-up ranged from 1 to 21 (average 4.9) months, with no recurrences. Twenty- three patients have died during the follow-up period, and there was no sign that reaccumulated pleural effusion existed in any, despite clinical evidence of systemic tumor progression. These observations indicate that intrapleural instillation of a slurry of iodized talc is a safe, adequate, and effective treatment for control of neoplastic or benign pleural effusions.

This article has been cited by other articles:

				P. A. Kvale, P. A. Selecky, and U. B. S. Prakash Palliative Care in Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 368S - 403S. [Abstract] [Full Text] [PDF]

				E. Marchi, F. S. Vargas, M. M. Acencio, L. Antonangelo, E. H. Genofre, and L. R. Teixeira Evidence that mesothelial cells regulate the acute inflammatory response in talc pleurodesis Eur. Respir. J., November 1, 2006; 28(5): 929 - 932. [Abstract] [Full Text] [PDF]

				N. A. Maskell, Y. C. G. Lee, F. V. Gleeson, E. L. Hedley, G. Pengelly, and R. J. O. Davies Randomized Trials Describing Lung Inflammation after Pleurodesis with Talc of Varying Particle Size Am. J. Respir. Crit. Care Med., August 15, 2004; 170(4): 377 - 382. [Abstract] [Full Text] [PDF]

				G Antunes, E Neville, J Duffy, and N Ali BTS guidelines for the management of malignant pleural effusions Thorax, May 1, 2003; 58(90002): ii29 - 38. [Full Text]

				M Henry, T Arnold, and J Harvey BTS guidelines for the management of spontaneous pneumothorax Thorax, May 1, 2003; 58(90002): ii39 - 52. [Full Text]

				S.-k. Mak, K. Nyunt, P.-n. Wong, K.-y. Lo, G. M.W. Tong, Y.-p. Tai, and A. K.M. Wong Long-term follow-up of thoracoscopic pleurodesis for hydrothorax complicating peritoneal dialysis Ann. Thorac. Surg., July 1, 2002; 74(1): 218 - 221. [Abstract] [Full Text] [PDF]

				E. M. Marom, J. J. Erasmus, J. E. Herndon II, C. Zhang, and H. P. McAdams Usefulness of Imaging-Guided Catheter Drainage and Talc Sclerotherapy in Patients with Metastatic Gynecologic Malignancies and Symptomatic Pleural Effusions Am. J. Roentgenol., July 1, 2002; 179(1): 105 - 108. [Abstract] [Full Text] [PDF]

				S. A. Sahn Talc Should Be Used for Pleurodesis Am. J. Respir. Crit. Care Med., December 1, 2000; 162(6): 2023 - 2024. [Full Text]

				G ANTUNES and E NEVILLE Management of malignant pleural effusions Thorax, December 1, 2000; 55(12): 981 - 983. [Full Text]

				M. Glazer, N. Berkman, J. S. Lafair, and M. R. Kramer Successful Talc Slurry Pleurodesis in Patients With Nonmalignant Pleural Effusion Chest, May 1, 2000; 117(5): 1404 - 1409. [Abstract] [Full Text] [PDF]

				Y. Ohta, Y. Tanaka, T. Hara, M. Oda, S.-i. Watanabe, J. Shimizu, and Y. Watanabe Clinicopathological and biological assessment of lung cancers with pleural dissemination Ann. Thorac. Surg., April 1, 2000; 69(4): 1025 - 1029. [Abstract] [Full Text] [PDF]

				E. M. Marom, E. F. Patz Jr, J. J. Erasmus, H. P. McAdams, P. C. Goodman, and J. E. Herndon Malignant Pleural Effusions: Treatment with Small-Bore-Catheter Thoracostomy and Talc Pleurodesis Radiology, January 1, 1999; 210(1): 277 - 281. [Abstract] [Full Text]

				A. P. C. Yim, A. T. C. Chan, T. W. Lee, I. Y. P. Wan, and J. K. S. Ho Thoracoscopic Talc Insufflation Versus Talc Slurry for Symptomatic Malignant Pleural Effusion Ann. Thorac. Surg., December 1, 1996; 62(6): 1655 - 1658. [Abstract] [Full Text]

				R. G. Cohen, W. W. Shely, S. E. Thompson, J. A. Hagen, C. C. Marboe, T. R. DeMeester, and V. A. Starnes Talc Pleurodesis: Talc Slurry Versus Thoracoscopic Talc Insufflation in a Porcine Model Ann. Thorac. Surg., October 1, 1996; 62(4): 1000 - 1002. [Abstract] [Full Text]